In the lawsuit filed in a state court in Chicago, a woman named Carrie Joiner alleged that the NDMA found in Zantac was the reason for her colorectal cancer. "Verdict is consistent with the ...

GSK also said it would pay $70 million to settle a related whistleblower lawsuit filed by a Connecticut ... First approved by US regulators in 1983, Zantac became the world’s best-selling ...

Over 75,000 plaintiffs filed suit in Delaware Superior Court alleging that ranitidine, which several manufacturers market under the trade name Zantac, caused their cancer. More specifically ...

After protracted legal battling, GSK has agreed to pay up to $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the Zantac heartburn medication caused cancer.

whose testing first raised the alarm about a link between Zantac and cancer. In that lawsuit, Valisure accused GSK of knowing that the drug elevates cancer risk and of keeping quiet about it.

The lawsuit alleges that the company misled investors about Zantac’s safety. “The company knew about its product’s link to cancer but kept it a secret for decades,” Yost said.

British drugs firm GSK has been accused of burying a report said to prove a link between its medication Zantac and cancer, a new lawsuit has claimed. A pension fund has filed a class action ...